-- 根據週五在上海證券交易所發布的公告顯示，大神林藥業集團（SHA:603233）第一季歸屬於股東的淨利潤年增11%，達到5.111億元人民幣，去年同期為近4.6億元。 每股盈餘較去年同期成長13%，從0.40元人民幣增至0.45元。 營業收入較去年同期成長0.3%，從69.6億元增至69.7億元。 該藥企股價收盤上漲1%。
Related Articles
Asia
Origin Energy Reports Lower March Quarter Production
Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.
$ASX:ORG
Asia
New Hope Says JPMorgan Chase Ceases to be a Substantial Shareholder
New Hope (ASX:NHC) received notice that JPMorgan Chase and its affiliates are no longer substantial holders of the company from April 22, according to a Monday filing with the Australian bourse.JPMorgan Chase and its affiliates became a substantial holder of the company on April 15, with a total voting power of 5.88%, an earlier filing showed.
$ASX:NHC
Asia
Zip Says JPMorgan Chase Increases Stake
Zip (ASX:ZIP) received notice that JPMorgan Chase and its affiliates increased their holdings in the company to 7.42% from 6.27%, according to a Monday Australian bourse filing.JPMorgan Chase and its affiliates now own 93.2 million shares in the company, the filing said.
$ASX:ZIP